News
Blood cancer is becoming a big killer but there are only a handful of ASX stocks fighting it
There are several ASX stocks fighting cancer but only a few are addressing blood cancers. The Leukaemia Foundation has released figures showing that blood cancers…
News
3 growing small cap ASX shares to watch
Are you looking to add some exposure to the small side of the market to your portfolio? Then you might want to get better acquainted…
News
Prescient Therapeutics (ASX:PTX) shares outperform on latest quarterly report
Prescient Therapeutics (PTX) outperformed its health sector peers on the ASX today after releasing its quarterly report for the three months to December 31. In…
News
Prescient Therapeutics chooses three cancer programs for its next-generation CAR T platform
Melbourne-based Prescient will focus development of its OmniCAR platform into three programs: the blood cancer acute myeloid leukemia (AML); solid tumours including breast, ovarian and…
News
Prescient Therapeutics (ASX:PTX) to begin three next-gen CAR T programs
Prescient Therapeutics (PTX) has announced three internal development programs for its immune receptor technology platform, OmniCAR. OmniCAR is a next-generation CAR T therapy platform that…
News
Ain’t no mountain high enough: Cancer survivor eyes Mt. Everest after revolutionary treatment
Following more than a decade of treatments, cancer survivor Laurie Adami now plans to tackle the world’s tallest mountain to raise awareness of the drugs…
News
How CAR T cancer treatment saved Laurie Adami’s life
An American woman who owes her life to a bespoke cancer treatment is speaking out to raise awareness of the procedure, CAR T cell therapy….
News
CAR-T Super Girl
Laurie Adami has had a long and intricate journey with blood cancer, after being diagnosed with Non-Hodgkin Lymphoma in 2006. Over the next 12 years,…
News
Is “next-gen” CAR-T the beginning of the end of cancer?
Cancer is a word we all dread to hear yet a cure for the deadly disease has always felt so far away. However, thanks to…
News
Prescient Therapeutics – Interview with Dr Allen Ebens
In the battle against blood cancer, chimeric antigen receptor T cell (CAR-T) therapy is proving to be a shining light on the horizon. Dr Allen…
RECENT POSTS
Categories
- Article (106)
- Media (13)
- News (305)
- Uncategorized (1)
- Webcast Video (7)